Loading clinical trials...

Determination In-vivo KUF for Diacap Pro Hemodialyser | Clinical Trials | Clareo Health

COMPLETEDNANCT02964429

Determination In-vivo KUF for Diacap Pro Hemodialyser

The main purpose of this study is the determination of the in-vivo ultrafiltration coefficient (in-vivo KUF) for Diacap Pro dialyzers following routine dialysis prescription in the United States.

Lead sponsor: B.Braun Avitum AG•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more

RECRUITINGNA

Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates

NCT06089473 · Kidney Disease, End-Stage, Frailty, and more

RECRUITING

Rutgers University Study of the Genetics of Kidney Disease

NCT07217535 · Kidney Disease, Kidney Disease, Chronic, and more

RECRUITING

TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation

NCT06801262 · Kidney Diseases, Kidney Transplant, and more

Active Not RecruitingPhase 4

Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant

NCT04665310 · Kidney Disease, End-Stage, Donor Specific Antibodies, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 7, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment12

Start dateNov 2016

Last updatedFeb 7, 2017

Condition

Kidney Failure,Chronic Renal Insufficiency,Chronic Kidney Disease, End-Stage Kidney Insufficiency

Locations shown

Interní oddělení Strahov VFN

Prague

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 7, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions